These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14063363)

  • 1. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION.
    KELSEY FO
    J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363
    [No Abstract]   [Full Text] [Related]  

  • 2. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 3. CONTROL EXPERIENCE WITH INVESTIGATIONAL NEW DRUGS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1963; 17():27-37. PubMed ID: 14083963
    [No Abstract]   [Full Text] [Related]  

  • 4. PROGRESS ON INVESTIGATIONAL DRUGS.
    RANKIN WB
    J New Drugs; 1963; 3(6):377-80. PubMed ID: 14113562
    [No Abstract]   [Full Text] [Related]  

  • 5. RULES, REGULATIONS AND RESEARCH.
    NEIBEL OJ
    New Physician; 1963 Dec; 12():A85-A87. PubMed ID: 14103668
    [No Abstract]   [Full Text] [Related]  

  • 6. REGULATIONS AFFECTING DRUG RESEARCH AND DEVELOPMENT: A HISTORICAL PERSPECTIVE.
    KLUMPP TG
    J New Drugs; 1963; 3(4):212-20. PubMed ID: 14063357
    [No Abstract]   [Full Text] [Related]  

  • 7. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
    WESTON JK; WESTON K
    Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
    [No Abstract]   [Full Text] [Related]  

  • 8. PROGRESS ON INVESTIGATIONAL DRUGS.
    RANKIN WB
    SD J Med Pharm; 1964 Mar; 17():42-5. PubMed ID: 14126560
    [No Abstract]   [Full Text] [Related]  

  • 9. THE PHYSICIAN AS FINAL ARBITER?
    PAGE I
    Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073
    [No Abstract]   [Full Text] [Related]  

  • 10. HOW THE FOOD AND DRUG ADMINISTRATION EVALUATES NEW DRUG APPLICATIONS.
    LARRICK GP
    J New Drugs; 1964; 4(2):63-74. PubMed ID: 14197105
    [No Abstract]   [Full Text] [Related]  

  • 11. THE PHYSICIAN AND THE FOOD AND DRUG ADMINISTRATION.
    SADUSK JF
    JAMA; 1964 Dec; 190():907-9. PubMed ID: 14214493
    [No Abstract]   [Full Text] [Related]  

  • 12. RECENT EXPERIENCES WITH EFFECTIVE NEW DRUG APPLICATIONS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1964; 18():1-6. PubMed ID: 14224959
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug innovation on the decline.
    Young D
    Am J Health Syst Pharm; 2007 Feb; 64(3):228, 231. PubMed ID: 17244865
    [No Abstract]   [Full Text] [Related]  

  • 14. THE FOOD AND DRUG ADMINISTRATION'S VIEW OF INVESTIGATIONAL DRUGS.
    MEYERS EL
    Am J Pharm Sci Support Public Health; 1963 Jun; 135():219-29. PubMed ID: 14046043
    [No Abstract]   [Full Text] [Related]  

  • 15. INVESTIGATIONAL DRUG REGULATIONS AND CLINICAL RESEARCH.
    GIBSON ML
    J Oral Ther Pharmacol; 1964 Jul; 1():93-8. PubMed ID: 14204421
    [No Abstract]   [Full Text] [Related]  

  • 16. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolution of new drug legislation.
    Kelsey FO
    BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
    [No Abstract]   [Full Text] [Related]  

  • 18. WASHINGTON AND NEW DRUGS. NEW REGULATIONS REQUIRE FILING OF SAFETY AND EFFICACY DATA FOR NEW DRUGS INTRODUCED SINCE 1938.
    LARRICK GP
    J New Drugs; 1964; 4(2):105-10. PubMed ID: 14197104
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug development for "orphan" diseases.
    Cerami A
    Am J Med; 1978 Sep; 65(3):407-8. PubMed ID: 717413
    [No Abstract]   [Full Text] [Related]  

  • 20. New drugs and the Kefauver-Harris amendment.
    Krantz JC
    J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.